Urology Times Innovation Celebration Video Series

“PSMA-PET imaging is something that from a clinical practice perspective is rapidly changing and evolving the field of prostate cancer,” says William P. Parker, MD.

"[Sacral neuromodulation has] changed the treatment of OAB remarkably," says Howard B. Goldman, MD, FACS.

Joshua A. Broghammer, MD, discusses the use of penile implants in the field of urology, detailing both the semi-rigid and inflatable penile prostheses.

“From a screening perspective, mpMRI really has changed how we evaluate men at risk for prostate cancer. It has improved the selection of men for biopsy and certainly improved our diagnostic rates,” says William P. Parker, MD.

Joshua A. Broghammer, MD, discusses the development and use of intracavernosal injections for the treatment of patients with erectile dysfunction.

"Bulking agents changed the paradigm of stress urinary incontinence treatment considerably," says Eric S. Rovner, MD.

“It’s pretty clear that over the past 50 years we've seen innovations in BPH treatment both from the utilization of technology and also from the patient outcome and experience standpoint,” says Bradley Gill, MD, MS.

"With regards to utilization of buccal mucosa graft in ureteral reconstruction, it's revolutionized the way that we can take care of patients with ureteral strictures, just as buccal mucosa graft revolutionized how urethral reconstruction is being done," says Ziho Lee, MD.